Al Hammadi Company for Development and Investment terminated the memorandum of understanding (MoU) signed with Sudair Pharma Co. for a potential acquisition.

 

The termination came as no final agreement was reached on the deal conditions, Al Hammadi said in statement to Tadawul on Sunday.

 

Last April, the healthcare services provider inked a two-month MoU with Sudair Pharma Co. for a potential acquisition of equity stake in the latter, Argaam reported.

 

Al Hammadi the preliminary agreement until Aug. 31.

Comments {{getCommentCount()}}

Be the first to comment

{{Comments.indexOf(comment)+1}}
{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
loader Train
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

Related News

Al Hammadi, Sudair Pharma extend MoU for potential acquisition
Al Hammadi, Sudair Pharma ink MoU for potential acquisition

Join Us

Argaam.com Copyright © 2026, Argaam Investment, All Rights Reserved
Call Request